A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis

NCT00002187 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Cytomegalovirus Retinitis
HIV Infections

Interventions

DRUG: Fomivirsen sodium

Sponsor

Ionis Pharmaceuticals, Inc.